Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001671927-25-000014
Filing Date
2025-08-07
Accepted
2025-08-07 07:01:04
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imcr-20250630.htm   iXBRL 10-Q 963419
2 EX-31.1 imcr-ex311q2.htm EX-31.1 10901
3 EX-31.2 imcr-ex312q2.htm EX-31.2 11259
4 EX-32.1 imcr-ex321q2.htm EX-32.1 7381
  Complete submission text file 0001671927-25-000014.txt   5286339

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imcr-20250630.xsd EX-101.SCH 36953
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imcr-20250630_cal.xml EX-101.CAL 58884
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imcr-20250630_def.xml EX-101.DEF 175776
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imcr-20250630_lab.xml EX-101.LAB 536544
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imcr-20250630_pre.xml EX-101.PRE 356521
65 EXTRACTED XBRL INSTANCE DOCUMENT imcr-20250630_htm.xml XML 614416
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)